Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial.
Notz Q, Heyland DK, Lee ZY, Menger J, Herrmann J, Chillon TS, Fremes S, Mohammadi S, Elke G, Mazer CD, Hill A, Velten M, Ott S, Kleine-Brueggeney M, Meybohm P, Schomburg L, Stoppe C.
Notz Q, et al. Among authors: menger j.
Intensive Care Med Exp. 2023 Dec 8;11(1):89. doi: 10.1186/s40635-023-00574-8.
Intensive Care Med Exp. 2023.
PMID: 38063975
Free PMC article.